Early-stage biotechnology company developing RNA-based therapeutics
miRecule develops next-generation RNA therapeutics to treat a variety of diseases including cancer and muscular dystrophy.
Where Ideas Become Reality- Life changing medical devices for everyone
Transforming cancer management
Transforming GI disease diagnosis and healthcare decision making
Developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue
Neuroimaging AI software solutions that transform outcomes for research, clinical trials, and care delivery
Data-driven medical insights for optimal postoperative recovery
Better informed decisions for diagnosis and treatment of glaucoma
Working at the frontier of vascular and musculoskeletal tissue regeneration
Building the future of intelligent pregnancy care.
Expanding the access to life-saving specialty drugs
Testing the immune fitness
Intelligent, adaptive, and personalized learning to tackle child literacy